Paradoxical inflammatory reactions associated with treatment of neurotuberculosis can lead to severe morbidity and mortality and may not be controlled by steroids alone. We report the use of the Janus kinase inhibitor ruxolitinib to treat a steroid-refractory neurotuberculosis paradoxical reaction.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Xie, Y. L., Ita-Nagy, F., Chen, R. Y., Manion, M. M., Sereti, I., Pei, L., & Holland, S. M. (2019). Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction with Ruxolitinib. Open Forum Infectious Diseases, 6(10). https://doi.org/10.1093/ofid/ofz422